Advanced search×

Prognostic impact of familial screening in dilated cardiomyopathy.

Michele M Moretti, Marco M Merlo, Giulia G Barbati, Andrea A Di Lenarda, Francesca F Brun, Bruno B Pinamonti, Dario D Gregori, Luisa L Mestroni, and Gianfranco G Sinagra

Eur J Heart Fail 12(9):922-7 (2010) PMID 20525703

Familial screening of patients with dilated cardiomyopathy (DCM) allows an early diagnosis of the disease in family members. It is unclear if familial forms (FDC) have a different long-term outcome compared with sporadic DCM. Our aim was to compare the long-term prognosis of FDC and sporadic forms in order to assess the role of familial screening.

DOI: 10.1093/eurjhf/hfq093
Version: za2963e q8zad q8zb7 q8zcb q8zd7 q8zeb q8zf6 q8zgb

Similar articles you may find interesting…

  1. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial.
    Miles McFall, Andrew J Saxon, ... CSP 519 Study Team

    JAMA 304(22):2485-93 (2010) PMID 21139110

    Most smokers with mental illness do not receive tobacco cessation treatment. To determine whether integrating smoking cessation treatment into mental health care for veterans with posttraumatic stress disorder (PTSD) improves long-term smoking abstinence rates. A randomized controlled trial of 943 s...
  2. Genetic predictors of fibrin D-dimer levels in healthy adults.
    Nicholas L NL Smith, Jennifer E JE Huffman, ... Caroline C Hayward

    Circulation 123(17):1864-72 (2011) PMID 21502573 PMCID PMC3095913

    We performed the first large-scale, genome-wide association search. Methods and Results- A genome-wide investigation of the genomic correlates of plasma D-dimer levels was conducted among 21 052 European-ancestry adults. Plasma levels of D-dimer were measured independently in each of 13 cohorts. Eac...
    View PDF
  3. Progress toward genetic tailoring of heart failure therapy.
    John H JH Lillvis and David E DE Lanfear

    Curr Opin Mol Ther 12(3):294-304 (2010) PMID 20521218

    Heart failure (HF) is a modern epidemic and a heterogeneous disorder with many therapeutic options. While the average response to each individual treatment is favorable, significant interindividual variation exists in the response to HF therapeutics. As a result, the optimal regimen for an individua...
    View PDF